Venetoclax
Roche,Abbvie
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax']
 the comparison of vflai, flai and 3+7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low-risk aml treated in gimema trials and real world et al. 
Gruppo Italiano Malattie EMatologiche dell'Adulto